Inhibited protein expression of GSK-3β and elevation of p-GSK-3β led to stimulation in glycogen synthesis and an improvement in glucose metabolism disorders, thereby alleviating insulin resistance (Guan et al., 2021). This evidence concerns the gene GSK3B and Insulin resistance.